Onco-Nephrology Updates in Practice
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Oral Abstract Session
Onco-Nephrology Updates in Practice
October 22, 2020 | 05:00 PM - 07:00 PM
Location: Simulive
Session Description
Oral Abstract Session
Learning Pathway(s)
Moderator
Presentations
- Risk Factors for AKI During Autologous Stem Cell Transplantation in AL Amyloidosis
05:00 PM - 07:00 PM
Ralph Nader, MD
Ralph Nader, MD
I was born in Michigan and shortly thereafter moved to Lebanon with my family, where I grew up and attended medical school at the American University of Beirut (AUB). I later went on to complete Internal Medicine residency and Nephrology fellowship training at the American University of Beirut - Medical Center. In July 2018, I moved to Boston, where I completed a second Nephrology fellowship at Boston Medical Center. I am currently a PGY2 in Internal Medicine at Boston Medical Center. Once I satisfy my US residency requirements, I plan to work as a nephrologist in an academic medical center. I have special interest for medical education, clinical research and renal transplantation.
Risk Factors for AKI During Autologous Stem Cell Transplantation in AL Amyloidosis
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Associations Between the Immunoglobulin Germline Gene Usage and the Tropism of Organ Involvement and Renal Amyloid Deposition Patterns in Immunoglobulin Light-Chain Amyloidosis by Mass Spectrometry
05:00 PM - 07:00 PM
Dan Yang Li, PhD
Dan Yang Li, PhD
Dan-yang Li, Ph.D. candidate, Renal Division, Department of Medicine, Peking University First Hospital; Renal Pathological Center, Institute of Nephrology, Peking University; Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China; Beijing, People’s Republic of China
Associations Between the Immunoglobulin Germline Gene Usage and the Tropism of Organ Involvement and Renal Amyloid Deposition Patterns in Immunoglobulin Light-Chain Amyloidosis by Mass Spectrometry
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Treatment of AL Amyloidosis with Daratumumab Monotherapy
05:00 PM - 07:00 PM
Roberta Fenoglio, MD, PhD
Roberta Fenoglio, MD, PhD
PLACE OF WORK:
CMID-Nephrology and Dialysis Unit and Center of Research of Immunopathology and Rare Diseases (ERK-net member), San Giovanni Bosco Hospital. Department of Clinical and Biological Sciences, University of Turin. Italy
WORK EXPERIENCES:
2014-today Nephrology and Dialysis Unit and Center of Research of Immunopathology and Rare Diseases (CMID), San Giovanni Bosco Hospital. Department of Clinical and Biological Sciences, University of Turin. Turin. Italy.
Present position: Clinical Researcher of Nephrology University of Turin
Clinical activity at the Nephrological Ward in which performs the kidney biopsies as chief operator and takes part in the management of therapeutic protocols of immunosuppressive drugs;
Outpatient service for the management of patients suffering from Amyloidosis;
Outpatient service for the management of patients with chronic renal failure;
Outpatient service for the management of patients with immunological disorders and rare diseases
Management of patients with onconephrologic disorders
Biopsies on native kidney (> 180).
2005-2014 MD at Nephrology and Transplant unit of “Maggiore della Carità” hospital, Novara, Italy.
Author / Co-Author of 52 publications on Pubmed
Author / Co-Author of 5 book chapters
Lecturer in over 50 National and International Congresses
Treatment of AL Amyloidosis with Daratumumab Monotherapy
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Immune Checkpoint Inhibitor Use in Kidney Transplant Recipients: A Multicenter Study
05:00 PM - 07:00 PM
Naoka Murakami, MD, PhD, FASN
Naoka Murakami, MD, PhD, FASN
Naoka Murakami, MD PhD, is an Instructor of Medicine at Harvard Medical School and a transplant nephrologist at Brigham and Women’s Hospital. Her primary research interest is allograft tolerance and T cell immunobiology. Her research project focuses on kidney tissue-specific antigens and the roles of immune checkpoint molecules in autoimmune kidney diseases and transplant. Her projects have been supported by NIH and American Society of Nephrology Carl W. Gottschalk Research Scholar Grant.
Immune Checkpoint Inhibitor Use in Kidney Transplant Recipients: A Multicenter Study
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Daily Caffeine Consumption and Risk of AKI Related to Platinum-Salt Chemotherapy: A Prospective Cohort Study
05:00 PM - 07:00 PM
Aghiles Hamroun, MD, MPH
Aghiles Hamroun, MD, MPH
Young French nephrologist, senior resident in the Lille University Hospital Center
PhD student (Public Health, Epidemiology), CKD-REIN study group
Interested in chemotherapy-related nephrotoxicity (among others)
Daily Caffeine Consumption and Risk of AKI Related to Platinum-Salt Chemotherapy: A Prospective Cohort Study
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Kidney and Cancer Outcomes with Standard vs. Kidney Protective Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma
05:00 PM - 07:00 PM
Gabrielle Côté, MD
Gabrielle Côté, MD
Dr Gabrielle Côté completed medical school at Laval University in 2014 and continued her internal medicine and nephrology residency there until 2019. After her training, she received board certification from the Royale College of Physicians of Canada (FRCPC). She is currently doing a clinical fellowship in Onco-Nephrology at the University of Toronto. Her current research interests are in Onco-Nephrology and in Quality improvement and patient safety.
Kidney and Cancer Outcomes with Standard vs. Kidney Protective Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Risk Factors for Nephrotoxicity with High-Dose Methotrexate (HDMTX) in Haematological Malignancies
05:00 PM - 07:00 PM
Darragh O'Donoghue, MBChB
Darragh O'Donoghue, MBChB
Risk Factors for Nephrotoxicity with High-Dose Methotrexate (HDMTX) in Haematological Malignancies
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Characterizing the Risk of Development of Proteinuria with Bevacizumab Therapy
05:00 PM - 07:00 PM
Tomas Ignacio Guerrero Nunez, MD
Tomas Ignacio Guerrero Nunez, MD
Tomas Guerrero is a first year nephrology fellow at The University of North Carolina at Chapel Hill. He did his medical school training and residency training at The Ohio State University in Columbus, Ohio. His interests include interventional nephrology, as well as onco-nephrology. He is married to his wife, Lauren, who mad his residency training and fellowship possible, and has a dog named Stella who is the very best dog in the world.
Characterizing the Risk of Development of Proteinuria with Bevacizumab Therapy
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- CKD Prevalence, Patterns of Treatment, and Outcomes in Patients with Cancer: A Population-Based Cohort Study
05:00 PM - 07:00 PM
Abhijat Kitchlu, MD, MS
Abhijat Kitchlu, MD, MS
Dr. Abhijat Kitchlu completed medical school at Western University, followed by postgraduate training in internal medicine and nephrology at the University of Toronto. He then completed a Master's in Clinical Epidemiology at the University of Toronto as part of the Clinician Scientist Training Program. He is currently a Staff Nephrologist and Director of the Onco-nephrology Program at the University Health Network in Toronto. He is an Assistant Professor in the Department of Medicine at the University of Toronto. His research and clinical interest include onco-nephrology (co-existing cancer and kidney disease), with specific focus on toxicities of cancer therapies and cancer treatment options in the setting of chronic kidney disease. He also has interest and expertise in the use of population-level healthcare administrative data for clinical research.
CKD Prevalence, Patterns of Treatment, and Outcomes in Patients with Cancer: A Population-Based Cohort Study
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Assessment of Estimated Glomerular Filtration Rate in a Cohort of 1200 Cancer Patients Using Serum Creatinine and Cystatin C
05:00 PM - 07:00 PM
Veronica Torres Costa e Silva, MD, PhD
Veronica Torres Costa e Silva, MD, PhD
PROFESSIONAL EXPERIENCE
São Paulo State Cancer Institute (ICESP)
2009 - Current
Position: Attendant Physician. Nephrology Division.
School of Medicine of the University of São Paulo
2017 - Current
Position:
Associate Professor
Advisor for the Master’s Program of Medical School. Internal Medicine Division.
Education
2019 - (currently on hold due to the pandemic)
Master in Clinical & Translational Science
Tufts University
2015 -- Current (to be concluded May 2021)
Post PhD in Nephrology
Institution: University of São Paulo, São Paulo, Brazil
Title: Critical Analysis of glomerular filtration in cancer patients
2003 – 2007
PhD in Medical Sciences - Nephrology
Institution: University of São Paulo, São Paulo, Brazil
Title: Acute Kidney Injury in Intensive Care Unity: epidemiological profile and validation of prognostic rates
Year of degree: 2007
Assessment of Estimated Glomerular Filtration Rate in a Cohort of 1200 Cancer Patients Using Serum Creatinine and Cystatin C
October 22, 2020 | 05:00 PM - 07:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
